Streetbeat News

Stock Prices

GDC

LDWY

MOMO

TEO

The article highlights five notable value stocks in the communication services sector, emphasizing their low P/E ratios as indicators of potential undervaluation. These stocks include Lendway, Telecom Argentina, KT, GD Culture Group, and Hello Gr, with recent earnings reports suggesting varied financial performance.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:45 pm

ALKS

INMD

KPRX

PROC

SYRS

The article identifies Kiora Pharmaceuticals, Procaps Gr, InMode, Alkermes, and Syros Pharmaceuticals as notable value stocks in the healthcare sector, based on their low P/E multiples. It provides recent earnings per share data for each company, indicating financial performance and potential risks associated with investing in value stocks.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:44 pm

DOCU

DocuSign shares are trading higher following Baird's decision to maintain a Neutral rating on the stock while increasing its price target from $50 to $65.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 2:43 pm

CHCI

PMT

SEVN

SQFT

Benzinga Insights identifies 5 value stocks in the real estate sector with low P/E multiples, suggesting undervaluation. The stocks include Seven Hills Realty Trust (SEVN), Comstock Holding Co (CHCI), PennyMac Mortgage IT (PMT), Presidio Property Trust (SQFT), and Urban Edge Props (UE), each showing recent financial performance and dividend yields.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:39 pm

ASML

GSK

RSP

Goldman Sachs highlights concerns over the U.S. stock market's heavy concentration in its largest tech stocks, suggesting a 'barbell approach' for investors to diversify. The top 10 U.S. stocks now represent 33% of the S&P 500 market cap, leading to market performance skew. The firm also sees investment opportunities in Japan and the healthcare sector, and highlights European GRANOLAS stocks for their lower valuations and solid performance.

Portfolio Pulse from Piero Cingari

March 11, 2024 | 2:38 pm

EQT

GNE

VTYX

U.S. stocks were lower on Monday, with the Dow Jones index falling over 150 points. EQT Corporation's shares dropped 8.4% after announcing a merger with Equitrans Midstream. Other notable declines include Ventyx Biosciences, MoneyLion Inc., Genie Energy Ltd., and several others, each falling due to various company-specific news such as clinical data reports, quarterly results, and strategic updates.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 2:37 pm

SLRN

Acelyrin Inc (NASDAQ:SLRN) announced positive results from its Phase 2b/3 trial of izokibep for Psoriatic Arthritis, meeting the primary endpoint with high statistical significance. The drug was well-tolerated, showing a favorable safety profile. Additionally, long-term data from a Phase 2b trial in hidradenitis suppurativa demonstrated no increased safety liability with longer-term treatment, with clinical improvements over time. SLRN shares rose 7.35% to $8.03.

Portfolio Pulse from Vandana Singh

March 11, 2024 | 2:32 pm

BNTX

BioNTech's stock price increased following the announcement that the company will present clinical trial data for its oncology pipeline at the American Association for Cancer Research Annual Meeting 2024.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 2:31 pm

PATH

UiPath (NYSE:PATH) has seen unusual options activity, with a bearish stance by big-money investors. Benzinga's options scanner revealed 8 significant trades, showing a sentiment split of 37% bullish and 62% bearish. The focus is on a price band between $19.0 and $30.0. Currently, PATH's stock is up by 0.76% at $23.84, with an RSI indicating a neutral position. An earnings release is anticipated in 2 days.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:30 pm

VEEV

Veeva Systems (NYSE:VEEV) has delivered an impressive average annual return of 21.04% over the past 10 years, outperforming the market by 10.55% annually. An initial investment of $100 in VEEV a decade ago would be worth $688.88 today, showcasing the impact of compounded returns on investment growth. Veeva Sys currently holds a market capitalization of $36.68 billion.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:30 pm